These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 36168673

  • 1. Pre-transplant angiotensin II receptor type I antibodies in pediatric renal transplant recipients: An observational cohort study.
    Pizzo H, Mirocha J, Choi J, Garrison J, Haas M, Zhang X, Kamil ES, Kim I, Jordan SC, Puliyanda DP.
    Pediatr Transplant; 2022 Dec; 26(8):e14400. PubMed ID: 36168673
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of AT1R antibody (AT1R-Ab) among Malaysian multi-ethnic population.
    Jalalonmuhali M, Caroll R, Deayton S, Emery T, Humphreys I, Lim SJ, Lim SK, Coates T.
    Hum Immunol; 2020 Dec; 81(12):679-684. PubMed ID: 32736900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C, Kang ZY, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH.
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [Abstract] [Full Text] [Related]

  • 6. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
    Sorohan BM, Ismail G, Berechet A, Obrișcă B, Constantinescu I, Mărunțelu I, Tacu D, Baston C, Sinescu I.
    Transpl Immunol; 2021 Jun; 66():101389. PubMed ID: 33838295
    [Abstract] [Full Text] [Related]

  • 11. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH.
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [Abstract] [Full Text] [Related]

  • 12. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, Zabińska M, Myszka M, Kamińska M, Hałoń A, Dawiskiba T, Szyber P, Sas A, Klinger M.
    Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
    [Abstract] [Full Text] [Related]

  • 13. Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies.
    Gold A, Fichtner A, Choukair D, Schmitt CP, Süsal C, Dragun D, Tönshoff B.
    Pediatr Nephrol; 2021 Mar; 36(3):725-729. PubMed ID: 33355703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
    Guzzo I, Morolli F, Camassei FD, Piazza A, Poggi E, Dello Strologo L.
    Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
    [Abstract] [Full Text] [Related]

  • 16. Pre-transplant AT1R antibodies correlate with early allograft rejection.
    Gareau AJ, Wiebe C, Pochinco D, Gibson IW, Ho J, Rush DN, Nickerson PW.
    Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
    [Abstract] [Full Text] [Related]

  • 17. Pre-transplant AT1R antibodies and long-term outcomes in kidney transplant recipients with a functioning graft for more than 5 years.
    Aziz F, Jung-Hynes B, Parajuli S, Redfield RR, Astor BC, Mandelbrot D, Hidalgo L, Djamali A.
    Clin Nephrol; 2020 Nov; 94(5):245-251. PubMed ID: 32870149
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.